Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.4097 | 0.5371 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.2111 | 0.2768 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0059 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.7628 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 1 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.7628 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.6662 | 0.6662 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.4522 | 0.4522 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.4522 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.4522 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 1 | 0.5 |
Brugia malayi | hypothetical protein | 0.0025 | 0.2111 | 0.2768 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0059 | 1 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.2111 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.6662 | 0.6662 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.4097 | 0.5371 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0044 | 0.6662 | 0.6662 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0044 | 0.6662 | 0.6662 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0044 | 0.6662 | 0.6662 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.4522 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.2111 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 1 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0044 | 0.6662 | 0.6662 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.4522 | 0.4522 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.2111 | 0.5 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0059 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0044 | 0.6662 | 0.8734 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.2111 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.4522 | 0.4522 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 1 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0059 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.7628 | 1 |
Brugia malayi | hypothetical protein | 0.0035 | 0.4522 | 0.5929 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0044 | 0.6662 | 0.6662 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0044 | 0.6662 | 0.8734 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.2111 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 1 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.4522 | 0.4522 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0112 | 0.0147 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.7628 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.4522 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.2111 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.4097 | 0.4097 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.